Recommendations for achieving interoperable and shareable medical data in the USA.

Drug development Public health

Journal

Communications medicine
ISSN: 2730-664X
Titre abrégé: Commun Med (Lond)
Pays: England
ID NLM: 9918250414506676

Informations de publication

Date de publication:
2022
Historique:
received: 12 10 2021
accepted: 20 06 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 23 7 2022
Statut: epublish

Résumé

Easy access to large quantities of accurate health data is required to understand medical and scientific information in real-time; evaluate public health measures before, during, and after times of crisis; and prevent medical errors. Introducing a system in the USA that allows for efficient access to such health data and ensures auditability of data facts, while avoiding data silos, will require fundamental changes in current practices. Here, we recommend the implementation of standardized data collection and transmission systems, universal identifiers for individual patients and end users, a reference standard infrastructure to support calibration and integration of laboratory results from equivalent tests, and modernized working practices. Requiring comprehensive and binding standards, rather than incentivizing voluntary and often piecemeal efforts for data exchange, will allow us to achieve the analytical information environment that patients need.

Identifiants

pubmed: 35865358
doi: 10.1038/s43856-022-00148-x
pii: 148
pmc: PMC9293957
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

86

Informations de copyright

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing interests.

Références

JAMA Intern Med. 2021 Aug 1;181(8):1040-1041
pubmed: 34152360
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
J Am Med Inform Assoc. 2021 Mar 1;28(3):650-652
pubmed: 33404593
Nature. 2017 May 31;546(7656):8
pubmed: 28569823
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
Learn Health Syst. 2020 Dec 06;5(1):e10253
pubmed: 33349796
Cell. 2021 Mar 18;184(6):1415-1419
pubmed: 33740447
JCO Precis Oncol. 2019 Oct 1;3:
pubmed: 32923847
Learn Health Syst. 2021 Jul 08;5(3):e10286
pubmed: 34277947
JAMA Intern Med. 2021 Aug 1;181(8):1065-1070
pubmed: 34152373
Learn Health Syst. 2021 Jun 22;5(3):e10279
pubmed: 34277945

Auteurs

Ana Szarfman (A)

U.S. Food and Drug Administration, Silver Spring, MD 20993 USA.

Jonathan G Levine (JG)

Independent Researcher, Rockville, MD 20855 USA.

Joseph M Tonning (JM)

Your Health Concierge, Inc., Bethesda, MD 20815 USA.

Frank Weichold (F)

U.S. Food and Drug Administration, Silver Spring, MD 20993 USA.

John C Bloom (JC)

College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907 USA.

Janice M Soreth (JM)

Independent Medical Consultant, Chevy Chase, 20815 MD USA.

Mark Geanacopoulos (M)

U.S. Food and Drug Administration, Silver Spring, MD 20993 USA.

Lawrence Callahan (L)

U.S. Food and Drug Administration, Silver Spring, MD 20993 USA.

Matthew Spotnitz (M)

Columbia University Irving Medical Center, New York, NY 10032 USA.

Qin Ryan (Q)

U.S. Food and Drug Administration, Silver Spring, MD 20993 USA.

Meg Pease-Fye (M)

U.S. Food and Drug Administration, Silver Spring, MD 20993 USA.

John S Brownstein (JS)

Harvard Medical School, Boston Children's Hospital, Boston, MA 02115 USA.

W Ed Hammond (W)

Duke Center for Health Informatics, Duke Clinical & Translational Science Institute, Durham, NC 27705 USA.

Christian Reich (C)

Columbia University Department of Biomedical Informatics, New York, NY 10032 USA.

Russ B Altman (RB)

Departments of Bioengineering, Genetics & Medicine, Stanford University, Stanford University School of Medicine, Stanford, CA 94305-4145 USA.

Classifications MeSH